Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
about
Non-instrumented incubation of a recombinase polymerase amplification assay for the rapid and sensitive detection of proviral HIV-1 DNALateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adultsPoint-of-care assays for tuberculosis: role of nanotechnology/microfluidics.How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South AfricaMicrochip-based ultrafast serodiagnostic assay for tuberculosis.Implementation of Point-of-Care Diagnostics in Rural Primary Healthcare Clinics in South Africa: Perspectives of Key Stakeholders.Existing and Emerging Technologies for Point-of-Care Testing.Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries.Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA impacts the rapid diagnosis of tuberculous meningitis in children.Evaluating operational specifications of point-of-care diagnostic tests: a standardized scorecard.Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?Will a quadruple multiplexed point-of-care screening strategy for HIV-related co-infections be feasible and impact detection of new co-infections in at-risk populations? Results from cross-sectional studies.Rapid detection of Mycobacterium tuberculosis by recombinase polymerase amplification.A sensitive urinary lipoarabinomannan test for tuberculosis.Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.Economic challenges associated with tuberculosis diagnostic development.Ensuring quality: a key consideration in scaling-up HIV-related point-of-care testing programs.Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and ZambiaPoint-of-Care HIV Testing and Linkage in an Urban Cohort in the Southern USDeveloping global health technology standards: what can other industries teach us?Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review.Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.PIMA Point of Care CD4+ Cell Count Machines in Remote MNCH Settings: Lessons Learned from Seven Districts in Zimbabwe.Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries.Pathogen-derived biomarkers for active tuberculosis diagnosisCauses of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu Teaching Hospital.An Assay System for Point-of-Care Diagnosis of Tuberculosis using Commercially Manufactured PCB Technology.Evidence of accessibility and utility of point-of-care diagnostics as an integral part of prevention of mother-to-child transmission services: systematic scoping review protocol.p24 revisited: a landscape review of antigen detection for early HIV diagnosis
P2860
Q21089662-C2AB86D2-D31C-4F07-9BF9-878E2B7BEB88Q24185754-A4B559F6-8F64-4EFD-B062-9BD2C49572CCQ27004505-8630CB73-5CDD-490F-8CD7-AB483C2366BEQ28730481-211A6582-A93E-4A43-A789-781838386C2DQ30371541-44A997D9-20B2-43FB-8D5C-EB0CF3D9D900Q30377861-02814420-606B-4998-A0B8-A387B9E41522Q34376474-648ACC8E-915C-430E-841E-4F4B9DE8CC1AQ34413592-1F11CAFB-CF2E-4DB9-ACF3-52165A84F35CQ34416005-FDCF2ECA-7CE2-41E4-94E8-5B027208EDDFQ34464448-86258913-4916-453D-A885-6C62B3E7E49BQ34579955-97248570-C58E-4DD6-9305-7B133ED2D1EEQ34707579-287C60F0-0B73-469B-BD29-3FBC3BDC68B9Q35223941-73C7DB30-5796-44D7-9240-D5EB584F4ACFQ35612512-BA8D4435-9EC3-46CF-B27B-AEF0AAF1BF2BQ36159840-5419BFA8-F815-4A62-AC49-4024D650D97FQ36160928-D1B2F2D0-50B7-4052-BD18-44755BE2DA49Q36868151-7761B96A-511B-4FBB-BEE0-B2E42DD86372Q37083998-33E7ED82-8EE2-4DAD-AA28-4A3BBAB72530Q37212220-D17514AF-C1F8-4B88-A090-5CB7B537B1F1Q37368049-470441F9-EAC5-4B66-B83A-38158B40DC59Q37501613-39FE9C7B-6751-413A-9CFE-A54CA13ED041Q37634044-372EEBAC-7DFE-4587-B247-23067BDEF974Q37705892-8D6376BA-29E4-4B4F-BFBE-D1F8A44FE487Q38059894-B373F283-5FAB-4F99-9811-3ACB991B9594Q38264903-CF5FAF5C-D593-4428-968E-9152411A0094Q38618992-00DC9464-55D8-4078-93D0-D02A3F8435B9Q38848961-8FCBB239-F048-4937-83C0-66D6CDADDD9BQ46182970-391F95AC-213D-4B89-9A5F-7A20D4C72041Q57150995-3062D44F-E37F-4391-8220-65580C2897BF
P2860
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
@en
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
@nl
type
label
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
@en
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
@nl
prefLabel
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
@en
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
@nl
P1433
P1476
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
@en
P2093
Madhukar Pai
Nitika Pant Pai
P577
2012-01-01T00:00:00Z